At a glance
ClinicalIndex Comparison RecordN/ACompleted· 78 enrolled
Drug / intervention
AirCurve 10 ASVdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PAP to PAP: CPAP vs ASV for Insomnia Randomized Controlled Trial
In Brief
A clinical study evaluating AirCurve 10 ASV for Insomnia and Sleep-Disordered Breathing. Completed, enrolled 78 participants across 1 site.
Detailed Summary
The study will determine which of two different types of positive airway pressure (PAP therapy) modes are more effective in reducing sleep breathing events in chronic insomnia patients and in decreasing insomnia severity.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInsomnia, Sleep-Disordered Breathing
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartFeb 2015
First PostedFeb 2015
Primary CompletionAug 2017
Study CompletionDec 2017
TodayJul 2026
First PostedFeb 18, 2015
Enrollment StartFeb 1, 2015
Primary CompletionAug 1, 2017
Study CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 11.4 years ago
Interventions
AirCurve 10 ASVdevice
Device is able to provide both ASV therapy and CPAP therapy modes.